NCT03538587 Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers Status COMPLETED Phase NA
NCT03496402 Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults (MICCHADO) Status ACTIVE_NOT_RECRUITING Phase NA
NCT03452774 SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry Status RECRUITING Phase N/A
NCT03434730 Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation Status COMPLETED Phase PHASE2
NCT03410875 A Phase II Study of the BRAF Inhibitor, Vemurafenib, Plus Obinutuzumab in Patients With Previously Untreated Classical Hairy Cell Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03404726 A Study to Investigate BAY2402234, a Dihydroorotate Dehydrogenase (DHODH) Inhibitor, in Myeloid Malignancies Status TERMINATED Phase PHASE1
NCT03399331 Honey or Olive Oil for Treating Oral Mucositis in Children and Adults With Leukemia Receiving Intensive Chemotherapy Status COMPLETED Phase PHASE1
NCT03373526 Effects of Aerobic Training and Inspiratory Muscle Training in Patients During Hematopoietic Stem Cell Transplantation Status UNKNOWN Phase NA
NCT03342196 Thiotepa Plus Fludarabine+ Melphalan as the Preparative Regime for Alternative Donor Transplantation Status COMPLETED Phase PHASE2
NCT03330691 A Feasibility and Safety Study of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03326921 HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant Status RECRUITING Phase PHASE1
NCT03319901 Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL Status RECRUITING Phase PHASE1/PHASE2
NCT03312205 CAR-T Cells for Relapsed or Refractory Haematopoietic and Lymphoid Malignancies Status UNKNOWN Phase PHASE1/PHASE2
NCT03281746 Effect of Prevention Education in Caries Formation in Pediatric Patients With Leukemia Status TERMINATED Phase NA
NCT03271515 Immunotherapy With Bispecific CAR-T Cells for B-Cell Lymphoma, ALL and CLL Status UNKNOWN Phase PHASE1
NCT03262298 Anti-CD22 CAR-T Cell Therapy Targeting B Cell Malignancies Status UNKNOWN Phase PHASE1/PHASE2
NCT03244306 A Phase 1 Study of CD22-CAR TCell Immunotherapy for CD22+ Leukemia and Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03226704 Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing Status ENROLLING_BY_INVITATION Phase N/A